TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Aug 2019: Trial registered, NCT04073706
  2. 18 Jan 2021: Trial started, NCT04073706

The trials

NCT04073706: Sentinel Node Biopsy in Endometrial Cancer

State
Under way
Phase
Phase 3
People
760 planned
Started
18 Jan 2021
Primary completion
Jan 2031
Arms
TH BSO with SNB
Results
None posted
  1. 29 Aug 2019: Trial registered
  2. 18 Jan 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Surgery or procedure.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.